4.5 Interaction with other medicinal products and other forms of interaction  
 No interaction  studies  have  been  performed.   
 In vitro studies  showed  that setmelanotide  has low potential  for pharmacokinetic  interactions  related  to cytochrome  P450  (CYP)  transporters  and plasma  protein  binding.  
 
